Company News, Patents

BMS Patents Hydantoin To Reduce Inflammation

Author Image

By: TOM BRANNA

Editor

Patent No. US 6,710,064 B2: Bristol-Myers Squibb Co., Princeton, NJ, earn-ed a patent for the use of hydantoin as an anti-inflammatory agent.

Keep Up With Our Content. Subscribe To Happi Newsletters